Brown Advisory’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.05M | Buy |
|
|||||
|
2025
Q1 | $3.19M | Buy |
|
|||||
|
2024
Q4 | $2.35M | Buy |
|
|||||
|
2024
Q3 | $2.42M | Buy |
|
|||||
|
2024
Q2 | $2.44M | Buy |
|
|||||
|
2024
Q1 | $1.99M | Buy |
|
|||||
|
2023
Q4 | $1.43M | Buy |
|
|||||
|
2023
Q3 | $980K | Buy |
|
|||||
|
2023
Q2 | $968K | Buy |
|
|||||
|
2023
Q1 | $804K | Buy |
|
|||||
|
2022
Q4 | $641K | Buy |
|
|||||
|
2022
Q3 | $574K | Buy |
|
|||||
|
2022
Q2 | $507K | Sell |
|
|||||
|
2022
Q1 | $501K | Buy |
|
|||||
|
2021
Q4 | $282K | Sell |
|
|||||
|
2021
Q3 | $276K | Sell |
|
|||||
|
2021
Q2 | $413K | Buy |
|
|||||
|
2021
Q1 | $325K | Buy |
|
|||||
|
2020
Q4 | $336K | Sell |
|
|||||
|
2020
Q3 | $546K | Buy |
|
|||||
|
2020
Q2 | $473K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $223K | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $263K | Sell |
|
|||||
|
2019
Q1 | $1.2M | Buy |
|
|||||
|
2018
Q4 | $1.06M | Buy |
|
|||||
|
2018
Q3 | $1.22M | Buy |
|
|||||
|
2018
Q2 | $1.07M | Buy |
|
|||||
|
2018
Q1 | $981K | Sell |
|
|||||
|
2017
Q4 | $948K | Buy |
|
|||||
|
2017
Q3 | $931K | Buy |
|
|||||
|
2017
Q2 | $786K | Sell |
|
|||||
|
2017
Q1 | $685K | Buy |
|
|||||
|
2016
Q4 | $405K | Sell |
|
|||||
|
2016
Q3 | $645K | Sell |
|
|||||
|
2016
Q2 | $654K | Buy |
|
|||||
|
2016
Q1 | $321K | Buy |
|
|||||
|
2014
Q2 | – | Sell |
|
|||||
|
2014
Q1 | $649K | Buy |
|
|||||
|
2013
Q4 | $610K | Buy |
|
|||||
|
2013
Q3 | $262K | Buy |
|
|||||
|
2013
Q2 | $274K | Buy |
|